Other: Registry
RadiationRegistry of cancer patients who receive proton radiation therapy.
NCT Number: NCT05151952
Clínica Universidad de Navarra Proton Therapy Unit is establishing a registry to capture the full radiation dosimetry delivered to the patient, baseline clinical data, and disease, toxicity and quality of life outcomes. The objectives are parameters prescribed and to have all patients treated at the proton therapy unit to be included in the registry to enable future analysis of treatment outcomes to assist in understanding, which patients can benefit from the use of protons.
Interested in participating?
Request InfoAll sexes
Observational
Clinica Universidad de Navarra, Pamplona, Navarre, Spain
Proton based radiation therapy has considerable dosimetric advantages over the standard photon based external beam radiation therapy, with an increased cost. Now, the clinical advantages, however, may not be identified in general, even with the improved dose distributions. In a large-scale evaluation, in time of personalized/ precision medicine, the impact of dosimetric benefit int clinical benefit meds registration studies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Registry of cancer patients who receive proton radiation therapy.
Time frame: 20 years
Clinical outcomes will be obtains from electronic chart including: images, blood test, pathology and clinical reports
Contact information is provided by the study sponsor or research team.
Clinica Universidad de Navarra, Universidad de Navarra
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04151342
Cancer, Cancer, Therapy-Related
Calgary, Alberta, Canada
View Trial DetailsNCT04376229
Cancer, Therapy-Related, Neoplasms
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07444216
Cancer, Therapy-Related, Neoplasms
Memphis, Tennessee, United States
View Trial DetailsNCT05684367
Breast Cancer, Breast Diseases
Gainesville, Florida, United States
View Trial Details